ctaIn mythology unicorns are skittish things, and in business they appear little easier to pin down. EP Vantage has compiled a list of private start-up companies in the healthcare arena that are widely considered to be worth more than $1bn; notably it features very few makers of human therapeutics.
Instead these unicorns are involved in cutting-edge computational research such as artificial intelligence, sequencing or virtual reality, or are in risky, unproven areas.
